CytomX Therapeutics

CTMX

NASDAQHealth Care

Income Statement

Total Revenue$138.1M

Gross Profit$138.1M

Operating Income$25M

EBITDA$37.94M

EBIT$32.09M

Pre-tax Income$-58.91M

Net Income$31.87M

Cash Equivalent$40.49M

Total Debt$11.15M

Book Value$-21.7M

Book Value Per Share-0.29

Return on Equity (ROE)-66.06%

Return on Assets (ROA)+26.44%

Return on Invested Capital (ROI)-66.06%

Net Profit Margin+23.08%

Current Ratio1.25

Quick Ratio1.21

Long-Term Debt / Equity0.00